Zaizov R - Search Results

1

Intraocular involvement of Burkitt's lymphoma in a Bedouin child.

Wysenbeek YS, Nissenkorn I, Cohen S, Ben-Sira I, Stark B, Zaizov R. Wysenbeek YS, et al. Among authors: zaizov r. Pediatr Hematol Oncol. 1987;4(4):309-14. doi: 10.3109/08880018709141283. Pediatr Hematol Oncol. 1987. PMID: 3152936

2

Improved outcome in childhood B-cell lymphoma with the intensified French LMB protocol.

Yaniv I, Fischer S, Mor C, Stark B, Goshen Y, Stein J, Cohen IJ, Zaizov R. Yaniv I, et al. Among authors: zaizov r. Med Pediatr Oncol. 2000 Jul;35(1):8-12. doi: 10.1002/1096-911x(200007)35:1<8::aid-mpo2>3.0.co;2-p. Med Pediatr Oncol. 2000. PMID: 10881001

3

Deferoxamine (Desferal)-induced ocular toxicity.

Kaplinsky C, Stark B, Goshen Y, Yaniv I, Bashara S, Zaizov R. Kaplinsky C, et al. Among authors: zaizov r. Pediatr Hematol Oncol. 1988;5(4):293-7. doi: 10.3109/08880018809037369. Pediatr Hematol Oncol. 1988. PMID: 3152975

4

Hodgkin disease in children: reduced tailored chemotherapy for stage I-II disease.

Yaniv I, Saab A, Cohen IJ, Goshen Y, Loven D, Stark B, Tamary H, Zaizov R. Yaniv I, et al. Among authors: zaizov r. J Pediatr Hematol Oncol. 1996 Feb;18(1):76-80. doi: 10.1097/00043426-199602000-00015. J Pediatr Hematol Oncol. 1996. PMID: 8556376

5

Effective preventive central nervous system therapy with extended triple intrathecal therapy and the modified ALL-BFM 86 chemotherapy program in an enlarged non-high risk group of children and adolescents with non-B-cell acute lymphoblastic leukemia: the Israel National Study report.

Stark B, Sharon R, Rechavi G, Attias D, Ballin A, Cividalli G, Burstein Y, Sthoeger D, Abramov A, Zaizov R. Stark B, et al. Among authors: zaizov r. Cancer. 2000 Jan 1;88(1):205-16. doi: 10.1002/(sici)1097-0142(20000101)88:1<205::aid-cncr28>3.0.co;2-7. Cancer. 2000. PMID: 10618625 Clinical Trial.

6

Decreased insulin-like growth factor-I receptor sites on circulating mononuclear cells from children with acute leukemia.

Eshet R, Silbergeld A, Zaizov R, Stark B, Freud E, Laron Z, Shamai Y. Eshet R, et al. Among authors: zaizov r. Pediatr Hematol Oncol. 2000 Apr-May;17(3):253-60. doi: 10.1080/088800100276433. Pediatr Hematol Oncol. 2000. PMID: 10779992

7

Childhood malignant thymoma: clinical, therapeutic, and immunohistochemical considerations.

Kaplinsky C, Mor C, Cohen IJ, Goshen Y, Yaniv I, Tamary H, Jaber L, Stark B, Stern S, Zaizov R. Kaplinsky C, et al. Among authors: zaizov r. Pediatr Hematol Oncol. 1992 Jul-Sep;9(3):261-8. doi: 10.3109/08880019209016594. Pediatr Hematol Oncol. 1992. PMID: 1525005

8

T-cell acute lymphoblastic leukemia following therapy of rhabdomyosarcoma.

Kaplinsky C, Frisch A, Cohen IJ, Goshen Y, Jaber L, Yaniv I, Stark B, Tamary H, Zaizov R. Kaplinsky C, et al. Among authors: zaizov r. Med Pediatr Oncol. 1992;20(3):229-31. doi: 10.1002/mpo.2950200310. Med Pediatr Oncol. 1992. PMID: 1574035

9

Methotrexate-induced leukoencephalopathy is treatable with high-dose folinic acid: a case report and analysis of the literature.

Cohen IJ, Stark B, Kaplinsky C, Weitz R, Matz S, Lerman P, Rakowsky E, Vogel R, Zaizov R. Cohen IJ, et al. Among authors: zaizov r. Pediatr Hematol Oncol. 1990;7(1):79-87. doi: 10.3109/08880019009034321. Pediatr Hematol Oncol. 1990. PMID: 2204409 Review.

10

Thymic humoral factor-gamma 2, an immunoregulatory peptide, enhances human hematopoietic progenitor cell growth.

Barak Y, Hahn T, Pecht M, Karov Y, Berrebi A, Zaizov R, Stark B, Buchner V, Burstein Y, Trainin N. Barak Y, et al. Among authors: zaizov r. Exp Hematol. 1992 Feb;20(2):173-7. Exp Hematol. 1992. PMID: 1544385

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters